News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
37,626 Results
Type
Article (2405)
Company Profile (39)
Press Release (35182)
Section
Business (14101)
Career Advice (76)
Deals (2073)
Drug Delivery (8)
Drug Development (4086)
Employer Resources (10)
FDA (427)
Job Trends (759)
News (20101)
Policy (1050)
Tag
Academia (143)
Alliances (3459)
Alzheimer's disease (43)
Antibody-drug conjugate (ADC) (13)
Approvals (429)
Bankruptcy (11)
Best Places to Work (473)
Biosimilars (10)
Biotechnology (29)
Breast cancer (14)
Cancer (98)
Career advice (64)
CAR-T (10)
Cell therapy (31)
Clinical research (3125)
Collaboration (72)
Compensation (31)
COVID-19 (179)
C-suite (20)
Data (73)
Diagnostics (460)
Drug discovery (8)
Duchenne muscular dystrophy (9)
Earnings (4142)
Events (5899)
Executive appointments (67)
FDA (463)
Funding (62)
Gene editing (11)
Gene therapy (11)
GLP-1 (59)
Government (146)
Healthcare (700)
Infectious disease (182)
Inflammatory bowel disease (10)
IPO (981)
Job creations (289)
Job search strategy (62)
Layoffs (35)
Legal (210)
Lung cancer (15)
Manufacturing (16)
Medical device (304)
Medtech (304)
Mergers & acquisitions (1138)
Metabolic disorders (26)
Neuroscience (78)
NextGen: Class of 2025 (352)
Non-profit (153)
Northern California (267)
Obesity (13)
Opinion (13)
Patents (12)
People (5577)
Phase I (1344)
Phase II (1574)
Phase III (833)
Pipeline (43)
Postmarket research (30)
Preclinical (581)
Radiopharmaceuticals (12)
Rare diseases (15)
Real estate (419)
Regulatory (786)
Research institute (142)
Resumes & cover letters (9)
Schizophrenia (10)
Series A (17)
Southern California (262)
Startups (487)
United States (1277)
Vaccines (22)
Weight loss (9)
Date
Today (7)
Last 7 days (40)
Last 30 days (190)
Last 365 days (2576)
2025 (187)
2024 (2610)
2023 (2858)
2022 (3750)
2021 (4048)
2020 (3471)
2019 (2061)
2018 (1554)
2017 (1795)
2016 (1624)
2015 (1833)
2014 (1369)
2013 (1188)
2012 (1396)
2011 (1332)
2010 (1181)
Location
Africa (42)
Arizona (13)
Asia (1843)
Australia (295)
California (607)
Canada (111)
China (31)
Colorado (13)
Connecticut (9)
Europe (3778)
Florida (35)
Illinois (13)
Indiana (24)
Kansas (12)
Maryland (21)
Massachusetts (216)
Minnesota (14)
New Jersey (40)
New York (36)
North Carolina (79)
Northern California (267)
Ohio (22)
Pennsylvania (27)
South America (40)
Southern California (262)
Texas (50)
Washington State (33)
37,626 Results for "xenetic biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Xenetic Biosciences, Inc. Announces Executive Leadership Transition
Xenetic Biosciences, Inc. today announced the appointment of James Parslow, the Company’s Chief Financial Officer, as interim Chief Executive Officer, effective May 16, 2024.
May 22, 2024
·
5 min read
Press Releases
Xenetic Biosciences, Inc. Reports Third Quarter 2024 Financial Results
November 13, 2024
·
6 min read
Press Releases
Xenetic Biosciences, Inc. Extends Research Agreement with the University of Virginia for the Advancement of its DNase-Based Oncology Platform
December 17, 2024
·
6 min read
Business
Xenetic Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
Xenetic Biosciences, Inc. today reported its financial results for the first quarter of 2024 and provided a business update.
May 10, 2024
·
6 min read
Business
Xenetic Biosciences, Inc. Reports Full Year 2023 Financial Results
Xenetic Biosciences, Inc. today reported its financial results for the year ended December 31, 2023.
March 22, 2024
·
6 min read
Press Releases
Xenetic Biosciences, Inc. Enters into Clinical Trial Services Agreement with PeriNess Ltd. to Accelerate Development of DNase I Oncology Program
December 5, 2024
·
6 min read
Press Releases
Xenetic Biosciences, Inc. Extends Research and Development Collaboration with The Scripps Research Institute to Advance DNase Platform
November 8, 2024
·
6 min read
News
Xenetic Biosciences, Inc. Announces Abstract Accepted for Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2024
October 22, 2024
·
1 min read
Press Releases
Xenetic Biosciences, Inc. Enters into Materials Transfer Agreement with Tokyo Medical University for the Advancement of Its DNase-Based Oncology Platform
October 18, 2024
·
6 min read
Press Releases
Xenetic Biosciences, Inc. Presents Positive Preclinical Data Highlighting the Potential of Co-Administration of DNase I with CAR T Cells in a Murine Model of Melanoma Lung Metastasis
November 22, 2024
·
7 min read
1 of 3,763
Next
